| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 49401-088 | BENLYSTA | belimumab | GlaxoSmithKline LLC | SOLUTION | 2017-07-20 | |
| 49401-101 | BENLYSTA | belimumab | GlaxoSmithKline LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2011-03-10 | |
| 49401-102 | BENLYSTA | belimumab | GlaxoSmithKline LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2011-03-10 |
Loading full table content...